CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Every figure this model derived for CLOV, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 2,825,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 238,564,000 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 485,446,000 AssetsCurrent 2026-06-30
current liabilities 323,330,000 LiabilitiesCurrent 2026-06-30
equity 376,257,000 StockholdersEquity 2026-06-30
interest expense 0 InterestExpenseNonoperating 2025-12-31
ocf 77,034,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 2,476,713,000 Revenues 2026-06-30
sbc 72,380,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up CLOV on one particular measure came for.

RatioValue
cash operating margin2.11
current ratio1.5
current ratio reported1.5
deferred revenue growth-99.98
dilution pct4.48
fcf margin3.0
growth cv1.54
operating margin-0.74
owner earnings margin0.07
revenue growth54.03
revenue growth per share47.43
roic-10.53
rule of 4053.29
sbc pct revenue2.92

What to be careful about

What this model itself distrusts about CLOV's figures. Written by the derivation as it ran, not added afterwards.